Mark Fairbrother is an experienced professional in pharmaceutical statistics programming with 20 years in the industry, primarily focusing on oncology. They have held various leadership roles, including Associate Director of Statistical Programming at AstraZeneca since 2025 and previously led projects at notable companies such as Roche and Novartis. Mark's expertise encompasses team development, vendor management, and navigating complex submissions across multiple phases of clinical trials. They hold a degree in Applied Statistics from Sheffield Hallam University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices